Cargando…
Development of a physiological insulin resistance model in human stem cell–derived adipocytes
Adipocytes are key regulators of human metabolism, and their dysfunction in insulin signaling is central to metabolic diseases including type II diabetes mellitus (T2D). However, the progression of insulin resistance into T2D is still poorly understood. This limited understanding is due, in part, to...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9205586/ https://www.ncbi.nlm.nih.gov/pubmed/35714187 http://dx.doi.org/10.1126/sciadv.abn7298 |
_version_ | 1784729162220568576 |
---|---|
author | Friesen, Max Khalil, Andrew S. Barrasa, M. Inmaculada Jeppesen, Jacob F. Mooney, David J. Jaenisch, Rudolf |
author_facet | Friesen, Max Khalil, Andrew S. Barrasa, M. Inmaculada Jeppesen, Jacob F. Mooney, David J. Jaenisch, Rudolf |
author_sort | Friesen, Max |
collection | PubMed |
description | Adipocytes are key regulators of human metabolism, and their dysfunction in insulin signaling is central to metabolic diseases including type II diabetes mellitus (T2D). However, the progression of insulin resistance into T2D is still poorly understood. This limited understanding is due, in part, to the dearth of suitable models of insulin signaling in human adipocytes. Traditionally, adipocyte models fail to recapitulate in vivo insulin signaling, possibly due to exposure to supraphysiological nutrient and hormone conditions. We developed a protocol for human pluripotent stem cell–derived adipocytes that uses physiological nutrient conditions to produce a potent insulin response comparable to in vivo adipocytes. After systematic optimization, this protocol allows robust insulin-stimulated glucose uptake and transcriptional insulin response. Furthermore, exposure of sensitized adipocytes to physiological hyperinsulinemia dampens insulin-stimulated glucose uptake and dysregulates insulin-responsive transcription. Overall, our methodology provides a novel platform for the mechanistic study of insulin signaling and resistance using human pluripotent stem cell–derived adipocytes. |
format | Online Article Text |
id | pubmed-9205586 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | American Association for the Advancement of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-92055862022-06-29 Development of a physiological insulin resistance model in human stem cell–derived adipocytes Friesen, Max Khalil, Andrew S. Barrasa, M. Inmaculada Jeppesen, Jacob F. Mooney, David J. Jaenisch, Rudolf Sci Adv Biomedicine and Life Sciences Adipocytes are key regulators of human metabolism, and their dysfunction in insulin signaling is central to metabolic diseases including type II diabetes mellitus (T2D). However, the progression of insulin resistance into T2D is still poorly understood. This limited understanding is due, in part, to the dearth of suitable models of insulin signaling in human adipocytes. Traditionally, adipocyte models fail to recapitulate in vivo insulin signaling, possibly due to exposure to supraphysiological nutrient and hormone conditions. We developed a protocol for human pluripotent stem cell–derived adipocytes that uses physiological nutrient conditions to produce a potent insulin response comparable to in vivo adipocytes. After systematic optimization, this protocol allows robust insulin-stimulated glucose uptake and transcriptional insulin response. Furthermore, exposure of sensitized adipocytes to physiological hyperinsulinemia dampens insulin-stimulated glucose uptake and dysregulates insulin-responsive transcription. Overall, our methodology provides a novel platform for the mechanistic study of insulin signaling and resistance using human pluripotent stem cell–derived adipocytes. American Association for the Advancement of Science 2022-06-17 /pmc/articles/PMC9205586/ /pubmed/35714187 http://dx.doi.org/10.1126/sciadv.abn7298 Text en Copyright © 2022 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC). https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial license (https://creativecommons.org/licenses/by-nc/4.0/) , which permits use, distribution, and reproduction in any medium, so long as the resultant use is not for commercial advantage and provided the original work is properly cited. |
spellingShingle | Biomedicine and Life Sciences Friesen, Max Khalil, Andrew S. Barrasa, M. Inmaculada Jeppesen, Jacob F. Mooney, David J. Jaenisch, Rudolf Development of a physiological insulin resistance model in human stem cell–derived adipocytes |
title | Development of a physiological insulin resistance model in human stem cell–derived adipocytes |
title_full | Development of a physiological insulin resistance model in human stem cell–derived adipocytes |
title_fullStr | Development of a physiological insulin resistance model in human stem cell–derived adipocytes |
title_full_unstemmed | Development of a physiological insulin resistance model in human stem cell–derived adipocytes |
title_short | Development of a physiological insulin resistance model in human stem cell–derived adipocytes |
title_sort | development of a physiological insulin resistance model in human stem cell–derived adipocytes |
topic | Biomedicine and Life Sciences |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9205586/ https://www.ncbi.nlm.nih.gov/pubmed/35714187 http://dx.doi.org/10.1126/sciadv.abn7298 |
work_keys_str_mv | AT friesenmax developmentofaphysiologicalinsulinresistancemodelinhumanstemcellderivedadipocytes AT khalilandrews developmentofaphysiologicalinsulinresistancemodelinhumanstemcellderivedadipocytes AT barrasaminmaculada developmentofaphysiologicalinsulinresistancemodelinhumanstemcellderivedadipocytes AT jeppesenjacobf developmentofaphysiologicalinsulinresistancemodelinhumanstemcellderivedadipocytes AT mooneydavidj developmentofaphysiologicalinsulinresistancemodelinhumanstemcellderivedadipocytes AT jaenischrudolf developmentofaphysiologicalinsulinresistancemodelinhumanstemcellderivedadipocytes |